Literature DB >> 25011444

Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender.

James R Hall1, April R Wiechmann, Leigh A Johnson, Melissa Edwards, Robert C Barber, Rebecca Cunningham, Meharvan Singh, Sid E O'Bryant.   

Abstract

BACKGROUND: Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) are a major factor in nursing home placement and a primary cause of stress for caregivers. Elevated cholesterol has been linked to psychiatric disorders and has been shown to be a risk factor for AD and to impact disease progression. The present study investigated the relationship between cholesterol and NPS in AD.
METHODS: Data on cholesterol and NPS from 220 individuals (144 females, 76 males) with mild-to-moderate AD from the Texas Alzheimer's Research and Care Consortium (TARCC) cohort were analyzed. The total number of NPS and symptoms of hyperactivity, psychosis, affect and apathy were evaluated. Groups based on total cholesterol (TC; ≥200 vs. <200 mg/dl) were compared with regard to NPS. The impact of gender was also assessed.
RESULTS: Individuals with high TC had lower MMSE scores as well as significantly more NPS and more symptoms of psychosis. When stratified by gender, males with high TC had significantly more NPS than females with high TC or than males or females with low TC.
CONCLUSION: The role of elevated cholesterol in the occurrence of NPS in AD appears to be gender and symptom specific. A cross-validation of these findings will have implications for possible treatment interventions, especially for males with high TC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25011444      PMCID: PMC4201880          DOI: 10.1159/000361043

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  34 in total

1.  Predictive validity of neuropsychiatric subgroups on nursing home placement and survival in patients with Alzheimer disease.

Authors:  Saw-Myo Tun; Daniel L Murman; Heidi L Long; Christopher C Colenda; Alexander von Eye
Journal:  Am J Geriatr Psychiatry       Date:  2007-04       Impact factor: 4.105

2.  Trajectories of behavioral disturbance in dementia.

Authors:  Tiffany W Chow; Jonathan D Fridhandler; Malcolm A Binns; Albert Lee; Jennifer Merrilees; Howie J Rosen; Robin Ketelle; Bruce L Miller
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study.

Authors:  G Zuliani; M Cavalieri; M Galvani; S Volpato; A Cherubini; S Bandinelli; A M Corsi; F Lauretani; J M Guralnik; R Fellin; L Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-18       Impact factor: 6.053

4.  An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative.

Authors:  Mahesh N Samtani; Michael Farnum; Victor Lobanov; Eric Yang; Nandini Raghavan; Allitia Dibernardo; Vaibhav Narayan
Journal:  J Clin Pharmacol       Date:  2011-06-09       Impact factor: 3.126

5.  Neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Constantine G Lyketsos; Maria C Carrillo; J Michael Ryan; Ara S Khachaturian; Paula Trzepacz; Joan Amatniek; Jesse Cedarbaum; Robert Brashear; David S Miller
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

6.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.

Authors:  Miia Kivipelto; Tiia Ngandu; Laura Fratiglioni; Matti Viitanen; Ingemar Kåreholt; Bengt Winblad; Eeva-Liisa Helkala; Jaakko Tuomilehto; Hilkka Soininen; Aulikki Nissinen
Journal:  Arch Neurol       Date:  2005-10

7.  High total cholesterol levels in late life associated with a reduced risk of dementia.

Authors:  M M Mielke; P P Zandi; M Sjögren; D Gustafson; S Ostling; B Steen; I Skoog
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

Review 8.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

9.  Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.

Authors:  Lauren P Wadsworth; Natacha Lorius; Nancy J Donovan; Joseph J Locascio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  Dement Geriatr Cogn Disord       Date:  2012-08-28       Impact factor: 2.959

Review 10.  Potential biomarkers in psychiatry: focus on the cholesterol system.

Authors:  Alisa G Woods; Izabela Sokolowska; Regina Taurines; Manfred Gerlach; Edward Dudley; Johannes Thome; Costel C Darie
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

View more
  4 in total

1.  Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol.

Authors:  Ozlem Gursoy Calan; Pinar Akan; Aysenur Cataler; Cumhur Dogan; Semra Kocturk
Journal:  Neurochem Res       Date:  2016-03-26       Impact factor: 3.996

2.  Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer's disease.

Authors:  James R Hall; April R Wiechmann; Rebecca L Cunningham; Leigh A Johnson; Melissa Edwards; Robert C Barber; Meharvan Singh; Scott Winter; Sid E O'Bryant
Journal:  Alzheimers Res Ther       Date:  2015-05-01       Impact factor: 6.982

3.  In vivo and in vitro studies on the roles of p38 mitogen-activated protein kinase and NADPH-cytochrome P450 reductase in Alzheimer's disease.

Authors:  Yunyi Yao; Jin-Zhong Huang; Liang Chen; Yingqi Chen; Xianhong Li
Journal:  Exp Ther Med       Date:  2017-09-22       Impact factor: 2.447

Review 4.  Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review.

Authors:  Mehak Agarwal; Safeera Khan
Journal:  Cureus       Date:  2020-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.